Taimei Technology - Logo white

Taimei Technology

Make Health Accessible for All with Innovative Digital Solutions for Life Sciences

Delivering Digital Solutions Globally to Empower Stakeholders in Life Science

Taimei Technology is a digital platform for Life Sciences, specializing in pharmaceutical R&D, drug safety, and medical marketing.

We create and develop innovative software solutions, including TrialOS for R&D collaboration and Infinity for academic exchange.

Our platforms connect all key players—pharmaceutical companies, hospitals, CROs, SMOs, doctors, and patients—using AI, big data, and cloud computing to streamline processes, enable seamless data flow, and enhance collaboration. This approach boosts efficiency in pharmaceutical R&D and post-market performance, adding value for all stakeholders.

Driven by our mission to “Harness Digital Power to Make Health Accessible”, we are building the infrastructure to accelerate drug launches, improve medication safety, increase access to effective treatments, and reduce patient costs.

 

1400+

Pharmaceutical Companies and CROs

Use Our Products and Services

≈700

National Clinical Trial Institutions

Partnered with Us

370+

SMOs

Have Partnered with Us

≈800

Cross-Disciplinary Pharma and IT Experts

Ensuring Innovation and Expertise

40+

Software Products and Digital Services

Professional Certifications and Qualifications

Compliance with
International Standards

  • Title 21 CFR Part 11
  • ICH-E2B
  • GAMP5
  • CDISC

Product Safety Meets
National Standards

  • Information System Security Level Protection (Level 3)
 

Certified by 6 International
ISO Standards

  • ISO 20000: Information Technology-Service Management
  • ISO 9001: Quality Management System
  • ISO 27001: Information Security Management System
  • ISO 27701: Privacy Information Management System
  • ISO 27018: Protection of personally identifiable information in cloud storage

Our Journey

2016 Business Expansion &
Platform Transformation

  • Secured RMB 30 million in Series B funding from Northern Light Venture Capital, Kaifeng Ventures, and Matrix Partners China
  • Secured RMB 100 million in Series C funding led by Loyal Valley Capital, with participation from Northern Light Venture Capital, Matrix Partners China, and Kaifeng Ventures
  • Secured RMB 300 million in Series D funding from Morningside Venture Capital, SAIF Partners, Zheshang Venture Capital, SoftBank China, Ivy Capital, and Kaifeng Ventures
  • Began offering pharmacovigilance services
  • Launched independent imaging evaluation services
  • Expanded business to the hospital sector
  • Released new products: eCollege, eImage, eTrial, and eSite

2022 Ongoing Platform Development and Global Expansion

  • Established branches in the U.S. and Singapore to drive international business
  • Launched products: eSAE, TrialPro, IDS
  • Released international versions of eCollect, eBalance, Paylite, eCooperate, and eArchives
 

2013 Company
Founded &
Key Products
Launched

  • Secured RMB 5 million in angel investment from Kaifeng Ventures
  • Secured RMB 20 million in Series A funding from Matrix Partners China
  • Launched key products: eCollect, eCooperate, eReport, eBalance, eSafety
  • Provided data management and statistical analysis services

2019 Business
Diversification

  • Secured RMB 700 million in Series E funding led by Tencent
  • Secured RMB 1.2 billion in Series F funding led by Tencent, Hillhouse Capital, Yunfeng Fund, and others
  • Launched the TrialOS platform
  • Acquired Softstone Technology to expand into digital marketing
  • Established Shengfang Pharmaceutical R&D to provide CRO services
  • Introduced digital SMO services
  • Launched products: eSAE, eScreening, GCP-X, iRMS, and the ONE series for the marketing sector

Recognitions

FORTUNE

2022 China’s Most Socially Impactful Startup

Hurun Report

2020-2021
Listed on the Hurun Global Unicorn List

IDC

Market Share Leader among Life Sciences R&D Information System Solution Providers in China

CBINSIGHTS

Digital Health TOP 150

FROST & SULLIVAN

Excellence in New Economy Innovation Award in China

Leader in Market Share for Certain SaaS Software Segments

ET / Fudan University School of Management

China’s Most Promising Enterprise Award

36 Kr

2018-2021

WISE King of Digital Healthcare

Listed among Top Digital Healthcare Companies

Vbdata.cn

2017-2021
VB100 Leader Enterprise 

TOP10
Ranked among the Top 100 in Digital Healthcare

EO Company

2017-2022
Best Innovative Technology Healthcare Company

CVINFO by China Venture

Top 10 Best Investment Cases in Healthcare Services

Venture 50 Ranking (2020-2021)

Fudan EY

China’s Most Promising Enterprise Award

High-Tech Enterprise of Zhejiang Province

Research and Development Center

National High-Tech Enterprise

Zhejiang Technology Small Giant Enterprise

Zhejiang Science and Technology Progress Award

Investors

2020-2021 Venture 50 Ranking (2020-2021)

Top 10 High-Quality Development Service Companies in Jiaxing City &

Outstanding Enterprise in Technological Innovation

 

Internet Weekly

Top 50 AI SaaS Influential Companies

Top 50 Healthcare Informatics Companies

6th China Innovation and Entrepreneurship Competition

4th Place in the National Finals (Biopharmaceutical Industry)

4th Zhejiang Province “Torch Cup” Innovation and Entrepreneurship Competition

Runner-Up in the Growth Group of the Biopharmaceutical Industry

Contact Us

Product Support：400-699-1906
Main Line：021-68825798
Business Inquiries: [email protected]
Media Partnerships: [email protected]

Scan to Follow Us on WeChat

Copyright 2023 Zhejiang Taimei Medical Technology Co., Ltd Zhejiang ICP No. 13033914
SLA | Privacy Policy - Taimei Medical Technology (taimei.com)